Ritonavir

CAS No. 155213-67-5

Ritonavir ( A-84538;ABT-538 )

Catalog No. M12207 CAS No. 155213-67-5

A potent HIV protease inhibitor for treatment of HIV-1 infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 28 In Stock
10MG 41 In Stock
25MG 65 In Stock
50MG 93 In Stock
100MG 133 In Stock
200MG 192 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ritonavir
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent HIV protease inhibitor for treatment of HIV-1 infection.
  • Description
    A potent HIV protease inhibitor for treatment of HIV-1 infection; also inhibits cytochrome P450-3A4 (CYP3A4).HIV Infection Approved
  • Synonyms
    A-84538;ABT-538
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIVProtease
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    155213-67-5
  • Formula Weight
    720.94
  • Molecular Formula
    C37H48N6O5S2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO; H2O:< 0.1 mg/mL
  • SMILES
    CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
  • Chemical Name
    2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Eagling VA, et al. Br J Clin Pharmacol, 1997, 44(2), 190-194.
2. Zeldin RK, et al. J Antimicrob Chemother. 2004 Jan;53(1):4-9.
molnova catalog
related products
  • L-870810

    A potent, selective inhibitor of HIV integrase (IC50=8-15 nM) with potent antiviral activity in cell culture and good pharmacokinetic properties.

  • (±)-BI-D

    A potent, allosteric HIV integrase inhibitor (Kd=34 nM) that binds the LEDGF/p75 binding site on integrase.

  • Raltegravir

    A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.